loader image
Saturday, January 10, 2026
73.9 F
McAllen
- Advertisement -

MSU Study Finds Placebos Reduce Stress, Anxiety, Depression

Even When People Know They Are Placebos

Translate to Spanish or other 102 languages!

A study out of Michigan State University found that nondeceptive placebos, or placebos given with people fully knowing they are placebos, effectively manage stress — even when the placebos are administered remotely.  Image for illustration purposes
A study out of Michigan State University found that nondeceptive placebos, or placebos given with people fully knowing they are placebos, effectively manage stress — even when the placebos are administered remotely.  Image for illustration purposes
- Advertisement -

By Shelly DeJong Michigan State University

EAST LANSING, Mich. – A study out of Michigan State University found that nondeceptive placebos, or placebos given with people fully knowing they are placebos, effectively manage stress — even when the placebos are administered remotely.  

Researchers recruited participants experiencing prolonged stress from the COVID-19 pandemic for a two-week randomized controlled trial. Half of the participants were randomly assigned to a nondeceptive placebo group and the other half to the control group that took no pills. The participants interacted with a researcher online through four virtual sessions on Zoom. Those in the nondeceptive placebo group received information on the placebo effect and were sent placebo pills in the mail along with instructions on taking the pills.    

- Advertisement -

The study, published in Applied Psychology: Health and Well-Being, found that the nondeceptive group showed a significant decrease in stress, anxiety and depression in just two weeks compared to the no-treatment control group. Participants also reported that the nondeceptive placebos were easy to use, not burdensome and appropriate for the situation. 

“Exposure to long-term stress can impair a person’s ability to manage emotions and cause significant mental health problems long-term, so we’re excited to see that an intervention that takes minimal effort can still lead to significant benefits,” said Jason Moser, co-author of the study and professor in MSU’s Department of Psychology. “This minimal burden makes nondeceptive placebos an attractive intervention for those with significant stress, anxiety and depression.” 

The researchers are particularly hopeful in the ability to remotely administer the nondeceptive placebos by health care providers. 

“This ability to administer nondeceptive placebos remotely increases scalability potential dramatically,” said Darwin Guevarra, co-author of the study and postdoctoral scholar at the University of California, San Francisco, “Remotely administered nondeceptive placebos have the potential to help individuals struggling with mental health concerns who otherwise would not have access to traditional mental health services.” 

- Advertisement -

By Shelly DeJong  

Read on MSUToday. 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Mayo Clinic Unveils EHR‑Integrated AI to Personalize Prostate Cancer Education

Mayo Clinic researchers have developed and evaluated MedEduChat, an electronic health record (EHR) that works with a large language model to provide accurate, patient-specific prostate cancer education.  

AMA Backs Updated Dietary Guidelines, Commits to Advancing Nutrition in Medicine

“The American Medical Association (AMA) applauds the Administration’s new Dietary Guidelines for spotlighting the highly processed foods, sugar-sweetened beverages, and excess sodium that fuel heart disease, diabetes, obesity, and other chronic illnesses. The Guidelines affirm that food is medicine and offer clear direction patients and physicians can use to improve health."

Study Shows a Sharp Drop in Teen Wellness Visits During Transition to Adulthood

It’s common that as kids get to high school and transition to adulthood, they begin to skip yearly wellness visits with a pediatrician or other primary care provider.

Wegovy® Pill, First Oral GLP‑1 for Weight Loss, Now Available Nationwide

Wegovy® pill is now available, providing those seeking help with their weight the revolutionary science of GLP-1 medicine in a pill for the first time.
- Advertisement -
×